Avricore Health Inc.

OTC: AVCRF · Healthcare · Medical - Diagnostics & Research

Canadian filerHQ Vancouver, BCCIK 0001355736Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 51

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, listing tenure · ↓ filing timeliness, Piotroski F

Methodology →

Revenue TTM

$104.5k

Rev growth YoY (TTM)

-96.5%

Net income (FY)

-$488.4k

Employees

Market cap

$3.5M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$488.4k-669.0k CAD2024

Total assets$1.6M2.3M CAD2024

Liabilities$229.9k330.8k CAD2024

Revenue by segment

Filed disclosures · FY2024

By product

Sale of products51%

Lease and service49%

By geography

Not disclosed.

The read

Avricore Health Inc. earned -$488.4k in FY2024 net income.

Peers · Healthcare

ZeroStack Corp.38D Enzolytics Inc.——Autonomix Medical, Inc.28D ENDRA Life Sciences Inc.26D

Key facts

CEORodger Seccombe

SectorHealthcare

IndustryMedical - Diagnostics & Research

HeadquartersVancouver, BC

ExchangeOTC: AVCRF

Employees26

IPO date2009-06-19

Latest filings

6-K2026-06-11 6-K2026-05-11 6-K2026-02-17 6-K2026-01-12 6-K2025-12-10 6-K2025-09-15 6-K2025-08-08 6-K2025-07-11

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.